Métastases en transit du mélanome : efficacité de l’imiquimod topique combiné au laser CO2 ou à l’électrocoagulation
Authors:
- 1 February 2014
- journal article
- case report
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 141 (2) , 106-110
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Local and intralesional therapy of in‐transit melanoma metastasesJournal of Surgical Oncology, 2011
- Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracilInvestigational New Drugs, 2011
- Isolated Limb Perfusion for Malignant Melanoma: Systematic Review on Effectiveness and SafetyThe Oncologist, 2010
- Effectiveness of imiquimod limited to dermal melanoma metastases, with simultaneous resistance of subcutaneous metastasisJournal of Cutaneous Pathology, 2009
- Predictors and Natural History of In-Transit Melanoma After Sentinel LymphadenectomyAnnals of Surgical Oncology, 2005
- Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy)Melanoma Research, 2005
- The natural course of cutaneous melanomaJournal of Surgical Oncology, 2004
- Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastasesBritish Journal of Cancer, 2003
- Topical imiquimod eradicates skin metastases of malignant melanoma but fails to prevent rapid lymphogenous metastatic spreadBritish Journal of Dermatology, 2002
- Imiquimod, a Topical Immune Response Modifier, in the Treatment of Cutaneous Metastases of Malignant MelanomaDermatology, 2002